Yulun Wang, Head of Research & Development at Teladoc Health, Inc. (TDOC), sold 2,500 shares at $199.24 ($498K) on 2020-12-14, disclosed to the SEC on 2020-12-16.
Open-market sale of $498k TDOC by Head of Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TDOC | SELL | 2021-01-22 | $1.9M | — | Filing → |
| TDOC | SELL | 2021-01-19 | $1.8M | — | Filing → |
| TDOC | SELL | 2020-12-07 | $1.2M | — | Filing → |